OpenAI Researcher Miles Wang Exits to Launch $2B AI Drug Discovery Startup
Miles Wang, a prominent OpenAI researcher known for accelerating scientific discovery with AI, is departing to establish an AI drug discovery startup. The new venture is reportedly seeking $200 million in funding at a $2 billion valuation, with Lightspeed potentially leading the round. This move, which may involve other OpenAI talents, signals strong investor confidence in leveraging advanced AI for life sciences breakthroughs, following similar successes like Chai Discovery and Isomorphic Labs. The startup aims to innovate drug development, possibly by repurposing existing medications, promising faster revenue generation.